Literature DB >> 17267208

Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: unravelling the IFNgamma pathway.

K Stoffels1, L Overbergh, R Bouillon, C Mathieu.   

Abstract

The activated form of vitamin D(3), 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), plays an important role in the immune system. Indeed, receptors for 1,25(OH)(2)D(3) are found on most immune cells, and 1alpha-hydroxylase, the enzyme responsible for final activation of vitamin D(3), is expressed by monocytes/macrophages, resulting in secretion of 1,25(OH)(2)D(3) after immune stimulation. We have previously shown that in murine peritoneal macrophages 1alpha-hydroxylase is highly regulated by immune signals such as IFNgamma and LPS. In the present study we made use of two different knock-out mouse models with disruptions in two key transcription factors in the IFNgamma-signalling cascade (STAT1alpha and IRF1), to evaluate their role in the regulation of 1alpha-hydroxylase. This was performed by culturing peritoneal macrophages from these knock-out mice in the presence of IFNgamma and LPS, and evaluating the impact of the absence of the respective transcription factors on 1alpha-hydroxylase mRNA expression by real-time RT-PCR. In addition also the mRNA expression profiles of the essential transcription factors STAT1alpha, IRF1 and C/EBPbeta were investigated. The data confirm a crucial role for STAT1alpha as well as for C/EBPbeta in the regulation of 1alpha-hydroxylase in monocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17267208     DOI: 10.1016/j.jsbmb.2006.12.091

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  24 in total

Review 1.  Minireview: Vitamin D: is there a role in extraskeletal health?

Authors:  Sylvia Christakos; Hector F DeLuca
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

2.  Can vitamin D reduce the risk of uterine fibroids?

Authors:  Ayman Al-Hendy; Marwa Badr
Journal:  Womens Health (Lond)       Date:  2014-07

3.  Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes.

Authors:  S Allegra; J Cusato; S De Francia; A Arduino; F Longo; E Pirro; D Massano; A De Nicolò; A Piga; A D'Avolio
Journal:  Pharmacogenomics J       Date:  2017-11-21       Impact factor: 3.550

Review 4.  Vitamin d deficiency in patients with chronic liver disease and cirrhosis.

Authors:  Lei Yuan Lim; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 5.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 6.  Vitamin D: metabolism.

Authors:  Sylvia Christakos; Dare V Ajibade; Puneet Dhawan; Adam J Fechner; Leila J Mady
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

Review 7.  Vitamin D signaling in the bovine immune system: a model for understanding human vitamin D requirements.

Authors:  Corwin D Nelson; Timothy A Reinhardt; John D Lippolis; Randy E Sacco; Brian J Nonnecke
Journal:  Nutrients       Date:  2012-03-15       Impact factor: 5.717

8.  In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection.

Authors:  Corwin D Nelson; Timothy A Reinhardt; Donald C Beitz; John D Lippolis
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 9.  Role of vitamin D in insulin resistance.

Authors:  Chih-Chien Sung; Min-Tser Liao; Kuo-Cheng Lu; Chia-Chao Wu
Journal:  J Biomed Biotechnol       Date:  2012-09-03

10.  Molecular phenotyping of immune cells from young NOD mice reveals abnormal metabolic pathways in the early induction phase of autoimmune diabetes.

Authors:  Jian Wu; Dorothy N Kakoola; Nataliya I Lenchik; Dominic M Desiderio; Dana R Marshall; Ivan C Gerling
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.